| Prev Close | 3.28 |
| Day Low/High | 3.19 / 3.29 |
| 52 Wk Low/High | 2.37 / 5.81 |
| Avg Volume | 74.80K |
| Exchange | NASDAQ |
| Shares Outstanding | 34.18M |
| Market Cap | 112.10M |
| EPS | 0.20 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
PSivida Announces 13 New Patents Issued Or Allowed
U.S. and foreign patents for bioerodible Medidur™, new smaller needle Medidur injector and Tethadur™
Primary Endpoint Met In PSivida's Utilization Study Of New Medidur™ Inserter With Smaller Diameter Needle
Results to Form Part of Planned Applications for Marketing Approvals in EU and US
PSivida Names Dario Paggiarino, M.D. As Chief Medical Officer
Industry Veteran Brings Over 25 Years of Pharmaceutical and Drug Development Experience
PSivida's Medidur™ Maintains Same High Statistical Significance In Primary Endpoint Through 12 Months In First Phase 3 Trial (p Less Than 0.00000001)
Incremental Risk of Elevated IOP Relative to Control Decreases Through Last Follow-up Visit
Data Shows PSivida's Tethadur™ Provides Prolonged, Sustained Release Of Avastin® With High Drug Efficacy
Data Presented at 2016 Annual Meeting & Exposition of the Controlled Release Society
PSivida Corp. Announces Plan To Consolidate All Research And Development In Current U.S. Facility
Plan to Facilitate Product Development and Reduce Operating Expenses
Investigator-Sponsored Phase 2 Study Results Show PSivida's Medidur® Fully Controlled Uveitis For Two Years With No Recurrence Of Disease While Visual Acuity Continued To Improve
Study Results Showing No Recurrence of Disease and Statistically Significant Improvement in Visual Acuity to be Published in Ophthalmology
PSivida Announces Successful Completion Of Two Preclinical Studies Of Durasert™ Sustained-Release Insert Delivering Repurposed Cancer Drug To Treat Wet AMD
Promising Results for Potential Sustained Treatment of Wet AMD Using a TKI
Today's Weak On High Volume Stock: PSivida (PSDV)
Trade-Ideas LLC identified pSivida (PSDV) as a weak on high relative volume candidate
Trade-Ideas: PSivida (PSDV) Is Today's Strong On High Relative Volume Stock
Trade-Ideas LLC identified pSivida (PSDV) as a strong on high relative volume candidate
